The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2016
Filed:
Apr. 15, 2014
Applicant:
Takeda Pharmaceutical Company Limited, Osaka, JP;
Inventors:
Takahiko Taniguchi, Kanagawa, JP;
Masato Yoshikawa, Kanagawa, JP;
Kasei Miura, Kanagawa, JP;
Tomoaki Hasui, Kanagawa, JP;
Eiji Honda, Kanagawa, JP;
Keisuke Imamura, Kanagawa, JP;
Makoto Kamata, Kanagawa, JP;
John F. Quinn, Albany, NY (US);
Joseph Raker, Delmar, NY (US);
Fatoumata Camara, Albany, NY (US);
Yi Wang, Hockessin, DE;
Assignee:
TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/10 (2006.01); C07D 401/14 (2006.01); A61K 31/437 (2006.01); A61K 31/4353 (2006.01); A61K 31/4355 (2006.01); A61K 31/4427 (2006.01); A61K 31/4985 (2006.01); A61K 31/5025 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/522 (2006.01); A61K 31/551 (2006.01); C07D 403/04 (2006.01); C07D 403/14 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 471/14 (2006.01); C07D 473/28 (2006.01); C07D 487/04 (2006.01); C07D 495/04 (2006.01); C07D 498/04 (2006.01); C07D 498/08 (2006.01); C07D 519/00 (2006.01); C07D 473/00 (2006.01); C07F 7/10 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4353 (2013.01); A61K 31/437 (2013.01); A61K 31/4355 (2013.01); A61K 31/444 (2013.01); A61K 31/4427 (2013.01); A61K 31/4439 (2013.01); A61K 31/4985 (2013.01); A61K 31/5025 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/522 (2013.01); A61K 31/551 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 471/14 (2013.01); C07D 473/00 (2013.01); C07D 473/28 (2013.01); C07D 487/04 (2013.01); C07D 495/04 (2013.01); C07D 498/04 (2013.01); C07D 498/08 (2013.01); C07D 519/00 (2013.01); C07F 7/10 (2013.01);
Abstract
The present invention provides a compound which has the effect of PDE inhibition, and which is useful as an agent for preventing or treating schizophrenia or so on represented by the formula (I):